Development of hepatitis B vaccine

JAMA

Volumn 302, Issue 3, 2009, Pages 322-324

  Beasley, R Palmer ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN VACCINE; HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER RISK; CLINICAL TRIAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; LIVER CELL CARCINOMA; NONHUMAN; NOTE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; VACCINATION; VIRUS TRANSMISSION; ANIMAL; HISTORY;

ANIMALS; HEPATITIS B; HEPATITIS B VACCINES; HISTORY, 20TH CENTURY; HUMANS;

EID: 67651070916     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1024     Document Type: Note

References (12)

1. Buynak EB, Roehm RR, Tytell AA, Bertland AU II, Lampson GP, Hilleman MR. Vaccine against human hepatitis B. JAMA. 1976;235(26):2832-2834.
2. Schmeck HM Jr. Vaccine for hepatitis B, judged highly effective, is approved by F.D.A. New York Times. November 17, 1981.
3. Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980;303(15):833-841.
4. Francis DP, Hadler SC, Thompson SE, et al. The prevention of hepatitis B with vaccine: report of the Centers for Disease Control multi-center efficacy trial among homosexual men. Ann Intern Med. 1982;97(3):362-366.
5. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292(15):771-774.
6. Beasley RP, Hwang LY, Lin CC, et al. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Lancet. 1981;2(8243):388-393.
7. Lee GC, Hwang LY, Beasley RP, Chen SH, Lee TY. Immunogenicity of hepatitis B virus vaccine in healthy Chinese neonates. J Infect Dis. 1983;148(3):526-529.
8. Beasley RP, Hwang LY, Lee GC, et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2(8359):1099-1102.
9. Beasley RP, Hwang LY. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis. 1983;147(2):185-190.
10. Beasley RP, Hwang LY, Lin CC, et al. Incidence of hepatitis B virus infections in pre-school children in Taiwan. J Infect Dis. 1982;146(2):198-204.
11. Beasley RP, Hwang LY, Lin CC, Ko YC, Twu SJ. Incidence of hepatitis among students at a university in Taiwan. Am J Epidemiol. 1983;117(2):213-222.
12. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan. Lancet. 1981;2(8256):1129-1133.